| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Investigation |
1 CEA–INSERM U797 Research Unit Neuroimaging in Psychiatry, Service Hospitalier Frédéric Joliot, IFR49, Orsay, and University of Paris-sud, Paris, France; and 2 CEA, DRM, DSV, Service Hospitalier Frédéric Joliot, Orsay, France
Correspondence: For correspondence or reprints contact: Claire Leroy, PhD, CEA-INSERM U797, Service Hospitalier Frédéric Joliot, 4 place du Général Leclerc, 91401 Orsay cedex, France. E-mail: claire.leroy{at}cea.fr
The high-resolution research tomograph (HRRT), dedicated to brain imaging, may offer new perspectives for identifying small brain nuclei that remain neglected by the spatial resolution of conventional scanners. However, the use of HRRT for neuroimaging applications still needs to be fully assessed. The present study aimed at evaluating the HRRT for measurement of the dopamine transporter (DAT) binding to validate its quantification and explore the gain induced by the increased spatial resolution in comparison with conventional PET scanners. Methods: Fifteen and 11 healthy subjects were examined using the selective DAT radioligand 11C-PE2I with HRRT and HR+ scanners, respectively. Quantification of the DAT binding was assessed by the calculation of binding potential (BP) values using the simplified reference tissue model in anatomic regions of interest (ROIs) defined on the dorsal striatum and in a standardized ROI defined on the midbrain. Results: Quantification of 11C-PE2I binding to the DAT measured in the midbrain and striatum with both scanners at the same spatial resolution (smoothed HRRT images) exhibited similar BP values and intersubject variability, thus validating the quantification of DAT binding on the HRRT. For age-paired comparison, BP values of subjects examined with HRRT were significantly higher than those of the subjects examined with HR+. The increase ranged from 29% in the caudate and 35% in the putamen to 92% in the midbrain. The decline in DAT binding with age in the striatum was in good agreement between both scanners and literature, whereas no significant decrease in DAT binding with age was observed in the midbrain with either HRRT or HR+. Conclusion: HRRT allows quantitative measurements of neurotransmission processes in small brain nuclei and allows recovering higher values as compared with coarser spatial resolution PET scanners. High-spatial-resolution PET appears promising for a more accurate detection of neurobiologic modifications and also for the exploration of subtle modifications in small and complex brain structures largely affected by the partial-volume effect.
Key Words: brain PET • high spatial resolution • high-resolution research tomography • dopamine transporter
COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.
This article has been cited by other articles:
|
|
 |
|
  C. Ciumas, T-B R. Wahlin, A. Jucaite, P. Lindstrom, C. Halldin, and I. Savic Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy Neurology, September 9, 2008; 71(11): 788 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Sureau, A. J. Reader, C. Comtat, C. Leroy, M.-J. Ribeiro, I. Buvat, and R. Trebossen Impact of Image-Space Resolution Modeling for Studies with the High-Resolution Research Tomograph J. Nucl. Med., June 1, 2008; 49(6): 1000 - 1008. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
